The global Platelet Function Test Market is set to experience robust growth from 2025 to 2035, with its market size projected to grow from USD 1,375.8 million in 2025 to USD 2,607.5 million by 2035 at ...
The global platelet function test market is projected to be valued at USD 1.38 billion in 2025 and is expected to reach USD 2.61 billion by 2035, registering a CAGR of 6.3% during the forecast period.
Is a medical journal ad for platelet-inhibition testing backed up by evidence that treatment guided by such testing can reduce the risk of clot formation? No, writes Yale cardiologist Harlan Krumholz.
Using platelet function testing to determine the optimal time for coronary artery bypass graft (CABG) surgery can shorten the waiting time before bypass in clopidogrel-treated patients without ...
Randomized trials of platelet function and genetic testing to guide antiplatelet decisions following PCI have produced notoriously mixed results: now, an updated consensus document aims to fill some ...
Platelets are small cells in the blood responsible for clotting of the damaged blood vessels. Blood vessels are responsible for carrying blood through the body. In an event when blood vessels are ...
SAN FRANCISCO, CA — Physicians are far more likely to order a VerifyNow (Accumetrics) platelet-function test for their patients with acute MI if the point-of-care assay is offered to them for free, ...
LOS ANGELES — Patients with intracranial aneurysm who respond poorly to the antiplatelet drug clopidogrel when treated with flow diversion using the Pipeline embolization device (Medtronic) have ...
Among patients with acute coronary syndromes undergoing a procedure such as angioplasty, those who received platelet function tests before receiving antithrombotic therapy to determine appropriate ...
A clinical trial of patients undergoing percutaneous coronary intervention (PCI) for acute coronary syndrome (ACS) and stable angina showed that a strategy of rapid genotyping followed by selective ...
While thrombocytopenia and bleeding are events that often occur together in neonates, this may not signify cause and effect. In fact, one study reported that 91% of neonates with low platelet counts ...
An experimental genetic test can gauge a person's risk of developing potentially deadly blood clots, researchers report. People who scored high on the test had more than double the rate of heart ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback